Antimicrobial resistance is a major public health threat. Monitoring and understanding the prevalence, mechanisms, and spread of antimicrobial resistance is a priority for patient care and global infection control strategies. Accurate identification of resistance determinants and correlation of antimicrobial resistance genetic profiles with antimicrobial treatment outcomes will help to develop personalized treatment regimens.

As a leading biotechnology company, Creative Diagnostics is at the forefront of developing advanced solutions for the detection of antimicrobial resistance genes. We offer customers a variety of advanced and effective assays to help them achieve rapid and accurate detection of resistance genes, increasing their ability to respond to drug resistance events in the clinic. https://antiviral.creative...